BIO-key International (BKYI) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
28 Nov, 2025Company overview and business model
Provides identity and access management (IAM) solutions for enterprise, education, and government sectors, focusing on secure, passwordless, and tokenless authentication.
Offers products such as PortalGuard, PortalGuard IDaaS, WEB-key biometric infrastructure, and biometric hardware, with a SaaS subscription model generating annual recurring revenue.
Expanded product offerings and customer base through the acquisition of Swivel Secure Europe, targeting EMEA markets.
Differentiates by enabling phone-less and token-less authentication, addressing needs in environments with roving workers and shared workstations.
Sells directly and through a network of over 150 channel partners, including resellers and system integrators.
Market opportunity and competitive landscape
Focuses on highly regulated industries such as government, financial services, and healthcare, with plans to expand in these sectors and EMEA.
Sees growth potential as enterprises seek to replace first-generation MFA solutions with more cost-effective, tokenless, and phoneless biometrics.
Anticipates increased demand due to heightened security and privacy requirements and compatibility with Windows 10 and 11.
Use of proceeds and capital allocation
Will not receive proceeds from the resale of shares by the selling stockholder.
May receive up to $3.8 million in gross proceeds if all Series A and B warrants are exercised, to be used for working capital, general corporate purposes, and partial repayment of a secured note.
Latest events from BIO-key International
- Vote proposed on a reverse stock split to regain Nasdaq compliance and enhance stock value.BKYI
Proxy Filing16 Mar 2026 - Vote on a reverse stock split to regain Nasdaq compliance and enhance stock marketability.BKYI
Proxy Filing6 Mar 2026 - Q1 2024 revenue up 19.5% sequentially, gross margin 86%, net loss narrowed, cash flow positive.BKYI
Q1 20243 Feb 2026 - Q2 revenue fell, but margins improved and new products, AWS entry, and financing support outlook.BKYI
Q2 20241 Feb 2026 - Q3 2024 revenue up 18%, net loss narrowed, but going concern risks remain.BKYI
Q3 202414 Jan 2026 - 2024 net loss cut nearly in half as shift to high-margin software and key partnerships drive gains.BKYI
Q4 202426 Dec 2025 - Shareholders to vote on directors, auditor, and executive pay, with annual say-on-pay recommended.BKYI
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and equity plan amendments.BKYI
Proxy Filing1 Dec 2025 - IAM SaaS firm registers 3.1M-share resale; proceeds from warrants to fund operations and debt.BKYI
Registration Filing28 Nov 2025